Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-03-02 Sale |
2023-03-03 09:18 am |
OPIANT PHARMACEUTICALS INC. | OPNT | CRYSTAL ROGER Chief Executive Officer 10% Owner |
87,106 | $20 | $1,742,120 | 0 (Direct) |
View |
| 2023-01-27 Sale |
2023-01-31 4:22 pm |
OPIANT PHARMACEUTICALS INC. | OPNT | CRYSTAL ROGER Chief Executive Officer 10% Owner |
1,358 | $20.26 | $27,513 | 75,339 (Direct) |
View |
| 2023-01-09 Sale |
2023-01-09 5:09 pm |
OPIANT PHARMACEUTICALS INC. | OPNT | CRYSTAL ROGER Chief Executive Officer 10% Owner |
1,183 | $20.2 | $23,897 | 76,697 (Direct) |
View |
| 2023-01-05 Sale |
2023-01-05 4:52 pm |
OPIANT PHARMACEUTICALS INC. | OPNT | CRYSTAL ROGER Chief Executive Officer 10% Owner |
5,029 | $20.2 | $101,586 | 77,880 (Direct) |
View |
| 2022-07-14 Sale |
2022-07-15 4:03 pm |
OPIANT PHARMACEUTICALS INC. | OPNT | CRYSTAL ROGER Chief Executive Officer 10% Owner |
2,246 | $11.11 | $24,953 | 82,909 (Direct) |
View |
| 2022-01-27 Sale |
2022-01-27 4:03 pm |
OPIANT PHARMACEUTICALS INC. | OPNT | CRYSTAL ROGER Chief Executive Officer 10% Owner |
1,995 | $26.15 | $52,169 | 78,488 (Direct) |
View |
| 2022-01-10 Sale |
2022-01-12 4:29 pm |
OPIANT PHARMACEUTICALS INC. | OPNT | CRYSTAL ROGER Chief Executive Officer 10% Owner |
1,058 | $30.49 | $32,258 | 80,483 (Direct) |
View |
| 2021-09-16 Purchase |
2021-09-16 4:12 pm |
OPIANT PHARMACEUTICALS INC. | OPNT | CRYSTAL ROGER Chief Executive Officer 10% Owner |
100 | $23.44 | $2,344 | 5,100 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-10 Option Award |
2024-06-12 4:13 pm |
N/A 2034-06-09 |
Mind Medicine (MindMed) Inc. | MNMD | CRYSTAL ROGER Director |
16,506 | $0 | 16,506 (Direct) |
View |
| 2023-06-21 Option Award |
2023-06-23 5:53 pm |
N/A 2033-06-20 |
Mind Medicine (MindMed) Inc. | MNMD | CRYSTAL ROGER Director |
32,874 | $0 | 46,890 (Direct) |
View |
| 2023-03-02 Option Award |
2023-03-03 09:18 am |
N/A N/A |
OPIANT PHARMACEUTICALS INC. | OPNT | CRYSTAL ROGER Chief Executive Officer 10% Owner |
6,667 | $0 | 0 (Direct) |
View |
| 2022-08-11 Option Award |
2022-08-15 9:55 pm |
N/A 2032-08-10 |
Mind Medicine (MindMed) Inc. | MNMD | CRYSTAL ROGER Director |
714,027 | $0 | 714,027 (Direct) |
View |
| 2022-06-27 Option Award |
2022-06-29 4:06 pm |
N/A N/A |
OPIANT PHARMACEUTICALS INC. | OPNT | CRYSTAL ROGER Chief Executive Officer 10% Owner |
6,667 | $0 | 85,155 (Direct) |
View |
| 2022-01-04 Option Award |
2022-01-05 4:15 pm |
N/A N/A |
OPIANT PHARMACEUTICALS INC. | OPNT | CRYSTAL ROGER Chief Executive Officer 10% Owner |
40,000 | $0 | 81,541 (Direct) |
View |
| 2021-01-26 Option Award |
2021-01-27 4:23 pm |
N/A 2031-01-26 |
OPIANT PHARMACEUTICALS INC. | OPNT | CRYSTAL ROGER Chief Executive Officer 10% Owner |
50,666 | $0 | 72,791 (Direct) |
View |